Ethical approval and consent to participate
Allogeneic Umbilical Cord Blood
CEREBRAL PALSY
Parents or representatives of all participant provided written informed consent to participate in the study. The study was adhered to the Declaration of Helsinki. Also, the protocol was approved by the institutional review board (No. 2015–06-093) of university hospital. The information is as below: Statement on ethics approval: (1) Title of the approved project: Mechanism of Allogeneic Umbilical Cord Blood Therapy in Cerebral Palsy. (2) Name of the institutional approval committee: Institutional Review Board of Bundang CHA Medical Center. (3) Approval number: 2015–06-093. (4) Date of approval: July 29, 2015.